George Budwell
George Budwell, PhD, is a contributing Motley Fool biotechnology and technology analyst covering disruptive innovators in healthcare, defense, and artificial intelligence. He also writes on portfolio theory, dividend stocks, and value investing. Prior to The Motley Fool, George was a freelance medical and science writer and a consultant for several life sciences hedge funds. Earlier in his career, he was an evolutionary biologist and completed postdoctoral fellowships at Kyoto University and Illinois State University. He holds a doctorate in evolutionary biology from Tulane University and a bachelor’s degree from Loyola University.
Recent Articles by George Budwell

2 AI Stocks to Buy Hand Over Fist Right Now

Is CoreWeave Stock Still a Buy After Its 200% Rally?

8 Quantum Computing Stocks to Buy Now

7 Artificial Intelligence (AI) Stocks to Buy Right Now

Why I'm Not Selling Archer Aviation Stock

2 Incredible Dividend Growth Stocks to Buy Now

3 Unstoppable Tech Stocks to Buy Hand Over Fist

1 Vanguard ETF Every Investor Should Consider

3 AI Stocks That Could Supercharge Your Portfolio

7 No-Brainer Dividend Growth Stocks to Buy Right Now

7 High-Powered Growth Stocks I'd Never Sell

2 No-Brainer Growth Stocks to Buy Right Now

Why I Own Joby Aviation Stock

2 Top AI Stocks to Buy Right Now

5 No-Brainer AI Stocks to Buy in May
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.